| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kinase binding | MYCN LYST TAOK2 PRAM1 SPDYE11 SPDYE15 PTPRK ZPR1 SPAG16 SPDYE14 MAPK8IP1 CACNB4 SPDYE17 SPDYE10 APBA1 DGKD SPDYE12 CCNA2 RHOA RHOC IBTK ABI2 SPDYE8 SMCR8 CDH1 PRLR EPHA4 | 7.06e-06 | 969 | 217 | 27 | GO:0019900 |
| GeneOntologyMolecularFunction | protein decrotonylase activity | 1.25e-05 | 5 | 217 | 3 | GO:0160008 | |
| GeneOntologyMolecularFunction | histone decrotonylase activity | 1.25e-05 | 5 | 217 | 3 | GO:0160009 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.69e-05 | 15 | 217 | 4 | GO:0005005 | |
| GeneOntologyMolecularFunction | protein kinase binding | LYST TAOK2 PRAM1 SPDYE11 SPDYE15 PTPRK ZPR1 SPAG16 SPDYE14 MAPK8IP1 CACNB4 SPDYE17 SPDYE10 APBA1 SPDYE12 CCNA2 RHOA RHOC IBTK SPDYE8 SMCR8 CDH1 PRLR EPHA4 | 2.94e-05 | 873 | 217 | 24 | GO:0019901 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 4.63e-05 | 19 | 217 | 4 | GO:0005003 | |
| GeneOntologyMolecularFunction | calcium ion binding | TRPM4 DCHS2 DNER PPP2R3B ACTN1 TENM2 RYR3 FAT1 PLCB3 LTBP4 DNASE1L2 CALU PPEF1 MYOF UNC13C CDH1 CDH3 PCDHGC3 RCN3 CDH17 RHOT1 | 7.20e-05 | 749 | 217 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | protein de-2-hydroxyisobutyrylase activity | 1.18e-04 | 2 | 217 | 2 | GO:0160010 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.29e-04 | 85 | 217 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | Krueppel-associated box domain binding | 3.50e-04 | 3 | 217 | 2 | GO:0035851 | |
| GeneOntologyMolecularFunction | glycine binding | 4.22e-04 | 14 | 217 | 3 | GO:0016594 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 7.04e-04 | 65 | 217 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | calmodulin binding | TRPM4 RYR3 PHKA1 SLC24A4 PLCB3 IQCJ-SCHIP1 CAMSAP1 STRN3 UNC13C | 9.59e-04 | 230 | 217 | 9 | GO:0005516 |
| GeneOntologyMolecularFunction | glial cell-derived neurotrophic factor receptor activity | 1.15e-03 | 5 | 217 | 2 | GO:0016167 | |
| GeneOntologyMolecularFunction | amino acid binding | 1.19e-03 | 73 | 217 | 5 | GO:0016597 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.25e-03 | 239 | 217 | 9 | GO:0031406 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 EPHB2 EPHB6 EPHA6 SPI1 ACTN1 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 FAT1 WNT3A UNC93B1 ROBO3 CAMSAP1 VCL FLNB ABI1 NRDC FGD2 ATG7 TGFB1 RHOA MFSD2A IGF1R ABI2 CDH1 CDH3 FGD6 CDH17 EPHA4 | 1.27e-07 | 1194 | 208 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | EPHB2 VCL NPHS1 RHOA RHOC ABI2 MARVELD2 PATJ CDH1 CDH3 CDH17 | 1.08e-06 | 167 | 208 | 11 | GO:0007043 |
| GeneOntologyBiologicalProcess | cell-cell junction organization | EPHB2 VCL NPHS1 TGFB1 RHOA RHOC ABI2 MARVELD2 PATJ CDH1 CDH3 CDH17 EPHA4 | 1.37e-06 | 246 | 208 | 13 | GO:0045216 |
| GeneOntologyBiologicalProcess | response to alkaloid | 5.05e-06 | 125 | 208 | 9 | GO:0043279 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 LGMN DNER ACTN1 PLXNB2 TAOK2 SRPX2 PTPRK WNT3A VCL NPHS1 CACNB4 TGFB1 RHOA RHOB RHOC IGF1R ABI2 MARVELD2 PATJ CDH1 CDH3 PCDHGC3 CDH17 EPHA4 SEZ6 | 5.92e-06 | 974 | 208 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | neuron projection development | CHL1 EPHB2 EPHB6 EPHA6 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 PTPRK WASHC5 ZPR1 WNT3A ROBO3 CAMSAP1 VCL ABI1 NRDC ATG7 AREG RHOA MFSD2A IGF1R PBRM1 ABI2 CDH1 HDAC2 EPHA4 SEZ6 | 1.50e-05 | 1285 | 208 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB2 DNER ACTN1 PLXNB2 TAOK2 SRPX2 PTPRK WNT3A VCL NPHS1 RHOA RHOC ABI2 MARVELD2 PATJ CDH1 CDH3 CDH17 | 1.99e-05 | 569 | 208 | 18 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 EPHB2 EPHB6 EPHA6 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 WNT3A ROBO3 VCL ABI1 NRDC ATG7 MFSD2A IGF1R ABI2 CDH1 EPHA4 | 2.38e-05 | 748 | 208 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB2 EPHB6 LGMN EPHA6 SPI1 F3 GFRA2 GFRA3 PTPRK WNT3A LTBP4 SCHIP1 ABI1 TMPRSS6 KCP DGKD AREG TGFB1 MYOF IGF1R PCSK6 INTS9 UBASH3B CDH3 PRLR HDAC1 HDAC2 EPHA4 | 2.44e-05 | 1186 | 208 | 28 | GO:0007167 |
| GeneOntologyBiologicalProcess | epithelium development | MYCN PYY CUL7 PLXNB2 PGR HDAC3 FAT1 WNT3A DNASE1L2 HOXB13 VCL FLNB ABI1 E2F4 AREG TGFB1 RHOA RHOB RHOC MFSD2A IGF1R PBRM1 ABI2 LTA4H MARVELD2 CDH1 CDH3 PRLR RCN3 HDAC1 HDAC2 EPHA4 | 3.00e-05 | 1469 | 208 | 32 | GO:0060429 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CHL1 EPHB6 DCHS2 SPI1 ACTN1 PLXNB2 TENM2 TAOK2 FAT1 SRPX2 VNN1 WNT3A ROBO3 VCL NPHS1 MAP3K8 SHB TGFB1 RHOA SART1 PBRM1 UBASH3B CDH1 CDH3 PCDHGC3 CDH17 | 3.37e-05 | 1077 | 208 | 26 | GO:0098609 |
| GeneOntologyBiologicalProcess | adherens junction organization | 3.42e-05 | 61 | 208 | 6 | GO:0034332 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TRPM4 SYNPO2L ACTN1 TAOK2 FAT1 WASHC5 SCN9A PLEKHH2 NPHS1 FLNB ABI1 FGD2 PSTPIP2 PSTPIP1 TGFB1 RHOA RHOB RHOC ABI2 CDH1 FGD6 HDAC2 MYBPC3 | 5.12e-05 | 912 | 208 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | response to caffeine | 5.26e-05 | 21 | 208 | 4 | GO:0031000 | |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 EPHB2 EPHB6 EPHA6 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 WNT3A ROBO3 VCL NRDC ATG7 IGF1R CDH1 EPHA4 | 6.47e-05 | 566 | 208 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CHL1 EPHB2 EPHB6 EPHA6 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 WNT3A ROBO3 VCL ABI1 NRDC ATG7 MFSD2A IGF1R ABI2 CDH1 EPHA4 | 6.51e-05 | 802 | 208 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SYNPO2L ACTN1 TAOK2 FAT1 WASHC5 PLEKHH2 NPHS1 FLNB ABI1 FGD2 PSTPIP2 PSTPIP1 TGFB1 RHOA RHOB RHOC ABI2 CDH1 FGD6 HDAC2 MYBPC3 | 6.62e-05 | 803 | 208 | 21 | GO:0030036 |
| GeneOntologyBiologicalProcess | neuron migration | 7.70e-05 | 218 | 208 | 10 | GO:0001764 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 EPHB2 EPHB6 EPHA6 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 WNT3A ROBO3 VCL ABI1 NRDC ATG7 MFSD2A IGF1R ABI2 CDH1 EPHA4 | 8.75e-05 | 819 | 208 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | axon development | CHL1 EPHB2 EPHB6 EPHA6 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 ZPR1 WNT3A ROBO3 VCL NRDC ATG7 IGF1R CDH1 EPHA4 | 9.45e-05 | 642 | 208 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | epithelial cell development | PGR FAT1 DNASE1L2 HOXB13 VCL FLNB E2F4 TGFB1 ABI2 MARVELD2 CDH1 | 9.50e-05 | 269 | 208 | 11 | GO:0002064 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 EPHB2 EPHB6 EPHA6 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 WNT3A ROBO3 VCL ABI1 NRDC ATG7 MFSD2A IGF1R ABI2 CDH1 EPHA4 | 9.85e-05 | 826 | 208 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell migration | 1.01e-04 | 2 | 208 | 2 | GO:1902766 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.22e-04 | 187 | 208 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 1.37e-04 | 78 | 208 | 6 | GO:0001825 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | EPHB2 EPHB6 SPI1 LYST VNN1 WNT3A MAP3K8 SHB TGFB1 RHOA SART1 PBRM1 PRLR | 1.54e-04 | 385 | 208 | 13 | GO:0051251 |
| GeneOntologyBiologicalProcess | neuron development | CHL1 EPHB2 EPHB6 EPHA6 CUL7 PLXNB2 TENM2 GFRA3 HOXA1 TAOK2 PTPRK WASHC5 ZPR1 WNT3A ROBO3 CAMSAP1 VCL ABI1 NRDC ATG7 AREG RHOA MFSD2A IGF1R PBRM1 ABI2 CDH1 HDAC2 EPHA4 SEZ6 | 1.61e-04 | 1463 | 208 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | MYCN PYY CUL7 PGR FAT1 DNASE1L2 HOXB13 VCL FLNB E2F4 TGFB1 RHOA PBRM1 ABI2 LTA4H MARVELD2 CDH1 CDH3 PRLR HDAC1 HDAC2 | 2.01e-04 | 870 | 208 | 21 | GO:0030855 |
| GeneOntologyBiologicalProcess | cellular response to insulin-like growth factor stimulus | 2.68e-04 | 13 | 208 | 3 | GO:1990314 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 3.01e-04 | 90 | 208 | 6 | GO:0043297 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 DCHS2 PLXNB2 TENM2 TAOK2 FAT1 ROBO3 CDH1 CDH3 PCDHGC3 CDH17 | 3.53e-04 | 313 | 208 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 3.74e-04 | 61 | 208 | 5 | GO:1904645 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | EPHB2 EPHB6 SPI1 LYST VNN1 WNT3A MAP3K8 SHB TGFB1 RHOA SART1 PBRM1 PRLR | 3.82e-04 | 423 | 208 | 13 | GO:0002696 |
| GeneOntologyBiologicalProcess | positive regulation of protein tyrosine kinase activity | 4.12e-04 | 35 | 208 | 4 | GO:0061098 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CHL1 EPHB2 EPHB6 TRPM4 BRINP3 EPHA6 DNER ACTN1 TENM2 PGR TAOK2 PTPRK WASHC5 ZPR1 GLRA1 IQCJ-SCHIP1 MAPK8IP1 MAF1 DPP6 FLNB STRN3 NRDC COPA APBA1 GLRA3 TGFB1 RHOA IGF1R ABI2 PRKAA2 HDAC1 EPHA4 SEZ6 | 2.52e-07 | 1228 | 211 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | axon | EPHB2 EXOC3 TENM2 PGR TAOK2 PTPRK ZPR1 GLRA1 SCN9A IQCJ-SCHIP1 ROBO3 MAPK8IP1 MAF1 ABI1 COPA ATG7 DTNA TGFB1 RHOA IGF1R PRKAA2 RIMBP2 UNC13C IL1R1 ENO1 CDH1 EPHA4 | 3.55e-07 | 891 | 211 | 27 | GO:0030424 |
| GeneOntologyCellularComponent | dendrite | CHL1 EPHB2 EPHB6 BRINP3 EPHA6 DNER ACTN1 TENM2 PGR TAOK2 PTPRK GLRA1 IQCJ-SCHIP1 MAPK8IP1 MAF1 STRN3 NRDC APBA1 GLRA3 RHOA ABI2 PRKAA2 EPHA4 SEZ6 | 6.56e-06 | 858 | 211 | 24 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CHL1 EPHB2 EPHB6 BRINP3 EPHA6 DNER ACTN1 TENM2 PGR TAOK2 PTPRK GLRA1 IQCJ-SCHIP1 MAPK8IP1 MAF1 STRN3 NRDC APBA1 GLRA3 RHOA ABI2 PRKAA2 EPHA4 SEZ6 | 6.82e-06 | 860 | 211 | 24 | GO:0097447 |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 TRPM4 BRINP3 DNER PGR PTPRK WASHC5 ZPR1 GLRA1 MAPK8IP1 DPP6 FLNB STRN3 COPA GLRA3 TGFB1 RHOA IGF1R PRKAA2 HDAC1 EPHA4 SEZ6 | 4.03e-05 | 835 | 211 | 22 | GO:0043025 |
| GeneOntologyCellularComponent | distal axon | EXOC3 TENM2 PGR TAOK2 ZPR1 GLRA1 MAPK8IP1 ABI1 COPA RIMBP2 UNC13C ENO1 CDH1 EPHA4 | 1.44e-04 | 435 | 211 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | cell body | EPHB2 TRPM4 BRINP3 DNER PGR PTPRK WASHC5 ZPR1 GLRA1 MAPK8IP1 DPP6 FLNB STRN3 COPA GLRA3 TGFB1 RHOA IGF1R PRKAA2 HDAC1 EPHA4 SEZ6 | 1.88e-04 | 929 | 211 | 22 | GO:0044297 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 ACTN1 TENM2 FAT1 PTPRK VCL NPHS1 RHOA ABI2 MARVELD2 PATJ CDH1 CDH3 PCDHGC3 CDH17 EPHA4 | 3.48e-04 | 591 | 211 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | LGMN WRNIP1 EXOC3 CUL7 RYR3 FAT1 GLB1 ZPR1 DAOA MAPK8IP1 MAF1 ATG7 CNTRL APBA1 PSTPIP1 TAMALIN RAB40C PATJ CDH1 HDAC1 SEZ6 | 5.25e-04 | 934 | 211 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | lamellipodium | 5.70e-04 | 230 | 211 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | dendritic spine | 8.18e-04 | 242 | 211 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | growth cone | 8.92e-04 | 245 | 211 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | neuron spine | 9.45e-04 | 247 | 211 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.12e-03 | 253 | 211 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | cell cortex | EXOC3 ACTN1 PLEKHH2 FLNB PSTPIP1 RHOA RIMBP2 UNC13C DCTN4 ENO1 CDH1 | 1.43e-03 | 371 | 211 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 ACTN1 TENM2 TAOK2 WNT3A ANO2 CACNB4 ABI1 NXPH1 APBA1 TAMALIN RHOA IGF1R ABI2 RIMBP2 ADGRA1 CDH1 EPHA4 | 1.65e-03 | 817 | 211 | 18 | GO:0098978 |
| Domain | Galactose-bd-like | 9.91e-08 | 94 | 209 | 10 | IPR008979 | |
| Domain | fn3 | CHL1 EPHB2 EPHB6 EPHA6 PTPRK ROBO3 NPHS1 IGF1R RIMBP2 PRLR EPHA4 MYBPC3 | 2.91e-07 | 162 | 209 | 12 | PF00041 |
| Domain | FN3_dom | CHL1 EPHB2 EPHB6 EPHA6 F3 PTPRK ROBO3 NPHS1 IGF1R RIMBP2 PRLR EPHA4 MYBPC3 | 6.92e-07 | 209 | 209 | 13 | IPR003961 |
| Domain | FN3 | CHL1 EPHB2 EPHB6 EPHA6 PTPRK ROBO3 NPHS1 IGF1R RIMBP2 PRLR EPHA4 MYBPC3 | 1.20e-06 | 185 | 209 | 12 | SM00060 |
| Domain | - | 1.55e-06 | 73 | 209 | 8 | 2.60.120.260 | |
| Domain | FN3 | CHL1 EPHB2 EPHB6 EPHA6 PTPRK ROBO3 NPHS1 IGF1R RIMBP2 PRLR EPHA4 MYBPC3 | 2.59e-06 | 199 | 209 | 12 | PS50853 |
| Domain | Pecanex_C | 5.48e-06 | 4 | 209 | 3 | PF05041 | |
| Domain | His_deacetylse_1 | 5.48e-06 | 4 | 209 | 3 | IPR003084 | |
| Domain | Pecanex | 5.48e-06 | 4 | 209 | 3 | IPR007735 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.40e-05 | 14 | 209 | 4 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.40e-05 | 14 | 209 | 4 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.40e-05 | 14 | 209 | 4 | IPR001426 | |
| Domain | EphA2_TM | 1.40e-05 | 14 | 209 | 4 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.40e-05 | 14 | 209 | 4 | IPR001090 | |
| Domain | Eph_TM | 1.40e-05 | 14 | 209 | 4 | IPR027936 | |
| Domain | EPH_lbd | 1.40e-05 | 14 | 209 | 4 | SM00615 | |
| Domain | Ephrin_lbd | 1.40e-05 | 14 | 209 | 4 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.40e-05 | 14 | 209 | 4 | IPR016257 | |
| Domain | EPH_LBD | 1.40e-05 | 14 | 209 | 4 | PS51550 | |
| Domain | Growth_fac_rcpt_ | 6.68e-05 | 156 | 209 | 9 | IPR009030 | |
| Domain | Ephrin_rec_like | 1.60e-04 | 25 | 209 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.60e-04 | 25 | 209 | 4 | IPR011641 | |
| Domain | Hist_deacetyl | 2.13e-04 | 11 | 209 | 3 | PF00850 | |
| Domain | - | 2.13e-04 | 11 | 209 | 3 | 3.40.800.20 | |
| Domain | His_deacetylse_dom | 2.13e-04 | 11 | 209 | 3 | IPR023801 | |
| Domain | His_deacetylse | 2.13e-04 | 11 | 209 | 3 | IPR000286 | |
| Domain | Cadherin | 3.67e-04 | 118 | 209 | 7 | IPR002126 | |
| Domain | Abi_HHR | 3.71e-04 | 3 | 209 | 2 | PF07815 | |
| Domain | Abl-interactor_HHR_dom | 3.71e-04 | 3 | 209 | 2 | IPR012849 | |
| Domain | Glycine_rcpt_A | 7.37e-04 | 4 | 209 | 2 | IPR008127 | |
| Domain | SH3 | PRAM1 MAPK8IP1 CACNB4 ABI1 PSTPIP1 ABI2 RIMBP2 ARHGAP27 UBASH3B | 7.52e-04 | 216 | 209 | 9 | SM00326 |
| Domain | SH3 | PRAM1 MAPK8IP1 CACNB4 ABI1 PSTPIP1 ABI2 RIMBP2 ARHGAP27 UBASH3B | 7.52e-04 | 216 | 209 | 9 | PS50002 |
| Domain | SH3_domain | PRAM1 MAPK8IP1 CACNB4 ABI1 PSTPIP1 ABI2 RIMBP2 ARHGAP27 UBASH3B | 8.56e-04 | 220 | 209 | 9 | IPR001452 |
| Domain | PH_dom-like | LYST PLEKHM2 PLCB3 PLEKHH2 MAPK8IP1 FGD2 SH3BP2 MTMR8 APBA1 DGKD PLEKHA6 ARHGAP27 FGD6 | 1.06e-03 | 426 | 209 | 13 | IPR011993 |
| Domain | GDNF_rcpt | 1.22e-03 | 5 | 209 | 2 | IPR003438 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 3.04e-07 | 41 | 157 | 7 | M232 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.33e-05 | 5 | 157 | 3 | MM15221 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.33e-05 | 98 | 157 | 8 | M39830 | |
| Pathway | REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1 | 2.64e-05 | 6 | 157 | 3 | M27072 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 4.59e-05 | 7 | 157 | 3 | MM15217 | |
| Pathway | PID_RB_1PATHWAY | 8.33e-05 | 65 | 157 | 6 | M279 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.03e-04 | 97 | 157 | 7 | MM15926 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS | 1.08e-04 | 9 | 157 | 3 | M27551 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.33e-04 | 101 | 157 | 7 | M39448 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.09e-04 | 11 | 157 | 3 | MM15046 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 2.09e-04 | 11 | 157 | 3 | M42523 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 3.24e-04 | 30 | 157 | 4 | M42517 | |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 26283270 | ||
| Pubmed | PYY PLXNB2 DHX15 SCN9A PLEKHH2 LTBP4 FLNB ABI1 RHOA IBTK IGF1R PCNX1 RIMBP2 FBXO21 CDH1 PRLR | 2.34e-09 | 371 | 220 | 16 | 15747579 | |
| Pubmed | Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. | 7.75e-09 | 5 | 220 | 4 | 27420561 | |
| Pubmed | 2.31e-08 | 6 | 220 | 4 | 21685935 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.22e-07 | 91 | 220 | 8 | 28558017 | |
| Pubmed | Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. | 1.91e-07 | 9 | 220 | 4 | 15148305 | |
| Pubmed | SRPK2 TENM2 TAOK2 HDAC3 UBAP2L CAMSAP1 WNK2 MAPK8IP1 STRN3 CACNB4 ABI1 SGIP1 SART1 RHOC PBRM1 ABI2 RIMBP2 ADGRA1 UBASH3B ENO1 HDAC2 EPHA4 | 2.46e-07 | 963 | 220 | 22 | 28671696 | |
| Pubmed | RhoA, RhoB and RhoC have different roles in cancer cell migration. | 2.50e-07 | 3 | 220 | 3 | 23488932 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 18212746 | ||
| Pubmed | A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. | 2.50e-07 | 3 | 220 | 3 | 12939257 | |
| Pubmed | RhoA, RhoB and RhoC differentially regulate endothelial barrier function. | 2.50e-07 | 3 | 220 | 3 | 28949796 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 23087373 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 18501342 | ||
| Pubmed | HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma. | 2.50e-07 | 3 | 220 | 3 | 27342975 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 21972094 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 26741994 | ||
| Pubmed | Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. | 2.50e-07 | 3 | 220 | 3 | 27147504 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 33637599 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 11358320 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 23475113 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 19362090 | ||
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. | 2.50e-07 | 3 | 220 | 3 | 19099586 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 29500478 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 20731616 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 20049841 | ||
| Pubmed | Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. | 2.50e-07 | 3 | 220 | 3 | 24821725 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 19477269 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 33670166 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 30279482 | ||
| Pubmed | HDAC1/2 and HDAC3 play distinct roles in controlling adult Meibomian gland homeostasis. | 2.50e-07 | 3 | 220 | 3 | 38679196 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 22673745 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 15642170 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 18347167 | ||
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma. | 2.50e-07 | 3 | 220 | 3 | 20415600 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYCN MBD1 RBM26 WRNIP1 SRPK2 MCM6 CUL7 A2ML1 CAMSAP1 HOXB13 ABI1 COPA MAP3K8 SART1 NOP14 ABI2 RCBTB1 TSHZ1 KDM1B HDAC2 | 6.40e-07 | 857 | 220 | 20 | 25609649 |
| Pubmed | 7.41e-07 | 12 | 220 | 4 | 25691658 | ||
| Pubmed | Histone deacetylases specifically down-regulate p53-dependent gene activation. | 9.94e-07 | 4 | 220 | 3 | 10777477 | |
| Pubmed | Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. | 9.94e-07 | 4 | 220 | 3 | 12393887 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 19912635 | ||
| Pubmed | Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. | 9.94e-07 | 4 | 220 | 3 | 10559899 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 24239178 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 26549030 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 22992742 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 15051733 | ||
| Pubmed | Expression of class I histone deacetylases during chick and mouse development. | 9.94e-07 | 4 | 220 | 3 | 20979029 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 9346952 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 25869072 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 33907245 | ||
| Pubmed | Class I HDAC activity is required for renal protection and regeneration after acute kidney injury. | 9.94e-07 | 4 | 220 | 3 | 24808536 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 17311813 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 11259576 | ||
| Pubmed | Class I histone deacetylase activity is required for proliferation of renal epithelial cells. | 9.94e-07 | 4 | 220 | 3 | 23698124 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 21637537 | ||
| Pubmed | XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. | 9.94e-07 | 4 | 220 | 3 | 12221096 | |
| Pubmed | Expression profile of class I histone deacetylases in human cancer tissues. | 9.94e-07 | 4 | 220 | 3 | 17786334 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 8662891 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RBM26 SRPK2 MCM6 ACTN1 DHX15 PHKA1 UBAP2L VCL PTCD3 FLNB STRN3 ABI1 COPA CORO2A CALU RHOA RHOB LTA4H DCTN4 PATJ ENO1 HDAC1 HDAC2 | 1.26e-06 | 1149 | 220 | 23 | 35446349 |
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 1.48e-06 | 14 | 220 | 4 | 12015313 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 1.99e-06 | 33 | 220 | 5 | 26864203 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 2.01e-06 | 15 | 220 | 4 | 17255939 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | LGMN MCM6 UBAP2L SUPT5H DNASE1L2 VCL FLNB COPA MAT2B MYOF UBASH3B ENO1 | 2.28e-06 | 344 | 220 | 12 | 30333137 |
| Pubmed | The methyl-CpG binding protein MBD1 is required for PML-RARalpha function. | 2.47e-06 | 5 | 220 | 3 | 16432238 | |
| Pubmed | Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. | 2.47e-06 | 5 | 220 | 3 | 10669754 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 22641068 | ||
| Pubmed | Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies. | 2.47e-06 | 5 | 220 | 3 | 26447190 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 20097764 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 8617235 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 24939842 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 12972430 | ||
| Pubmed | Beyond E-cadherin: roles of other cadherin superfamily members in cancer. | 2.47e-06 | 5 | 220 | 3 | 24442140 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 23624624 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 20473547 | ||
| Pubmed | LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. | 2.47e-06 | 5 | 220 | 3 | 17785205 | |
| Pubmed | Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. | 2.47e-06 | 5 | 220 | 3 | 14976551 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 33601056 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 19015268 | ||
| Pubmed | Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling. | 2.47e-06 | 5 | 220 | 3 | 18316616 | |
| Pubmed | GATA3 acetylation at K119 by CBP inhibits cell migration and invasion in lung adenocarcinoma. | 2.47e-06 | 5 | 220 | 3 | 29453984 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 10581039 | ||
| Pubmed | Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. | 2.47e-06 | 5 | 220 | 3 | 21143702 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 15093731 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 8543060 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 27012186 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 28497810 | ||
| Pubmed | Identification and mapping of human histone acetylation modifier gene homologues. | 2.47e-06 | 5 | 220 | 3 | 9722949 | |
| Pubmed | HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition. | 2.47e-06 | 5 | 220 | 3 | 31097476 | |
| Pubmed | Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. | 2.47e-06 | 5 | 220 | 3 | 17245431 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 12711603 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 15713663 | ||
| Pubmed | Role of NonO-histone interaction in TNFalpha-suppressed prolyl-4-hydroxylase alpha1. | 2.47e-06 | 5 | 220 | 3 | 18439917 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MBD1 RBM26 WRNIP1 PPP2R3B MCM6 ACTN1 HOXA1 UBAP2L LTBP4 FLNB ABI1 CNTRL DGKD ABI2 ENO1 | 3.29e-06 | 560 | 220 | 15 | 21653829 |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 3.48e-06 | 17 | 220 | 4 | 12217323 | |
| Pubmed | 3.48e-06 | 17 | 220 | 4 | 14519686 | ||
| Pubmed | WRNIP1 TENM2 TAOK2 WASHC5 UBAP2L CAMSAP1 WNK2 PTCD3 MAPK8IP1 FLNB STRN3 CACNB4 ABI1 SGIP1 DTNA NXPH1 APBA1 ABI2 FAM169A CRYBG3 ENO1 HDAC2 | 3.86e-06 | 1139 | 220 | 22 | 36417873 | |
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 11641274 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 9438836 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 11777905 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 26679995 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 18245468 | ||
| Pubmed | Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1. | 4.92e-06 | 6 | 220 | 3 | 11302704 | |
| Interaction | ANK3 interactions | CHL1 EPHB2 SRPK2 MCM6 MAPK8IP1 FLNB DTNA E2F4 RHOA RHOB ABI2 ENO1 CDH1 | 1.79e-07 | 201 | 208 | 13 | int:ANK3 |
| Interaction | PIK3R1 interactions | EPHB2 EPHB6 HOXA1 HDAC3 PTPRK IKZF3 ABI1 COPA FGD2 SHB TGFB1 RHOA RHOB RHOC IGF1R IL1R1 CDH1 EPHA4 | 3.00e-07 | 412 | 208 | 18 | int:PIK3R1 |
| Interaction | BAIAP2 interactions | EPHB2 MYCN RBM26 SRPK2 ABI1 NRDC RHOA RHOB ABI2 PATJ CDH1 EPHA4 | 1.25e-06 | 201 | 208 | 12 | int:BAIAP2 |
| Interaction | NOTCH1 interactions | MBD1 DNER HOXA1 DHX15 WNT3A TRAPPC9 IKZF3 APBA1 RHOA SART1 RHOB RHOC PBRM1 CDH1 HDAC1 | 3.20e-06 | 345 | 208 | 15 | int:NOTCH1 |
| Interaction | TENM2 interactions | 5.11e-06 | 12 | 208 | 4 | int:TENM2 | |
| Interaction | GANAB interactions | MCM6 CUL7 SUPT5H COPA CALU CNTRL E2F4 TGFB1 RHOA RHOB RHOC IGF1R DCTN4 HDAC1 HDAC2 | 6.98e-06 | 368 | 208 | 15 | int:GANAB |
| Interaction | BAIAP2L1 interactions | 7.86e-06 | 129 | 208 | 9 | int:BAIAP2L1 | |
| Interaction | RIPOR2 interactions | 1.38e-05 | 15 | 208 | 4 | int:RIPOR2 | |
| Interaction | PLEKHA1 interactions | 1.64e-05 | 108 | 208 | 8 | int:PLEKHA1 | |
| Interaction | CCN5 interactions | 1.82e-05 | 16 | 208 | 4 | int:CCN5 | |
| Interaction | WASF2 interactions | 2.13e-05 | 146 | 208 | 9 | int:WASF2 | |
| Interaction | HDAC3 interactions | SPI1 KDM4C MBD1 PGR HDAC3 PRAM1 SUPT5H NRDC CORO2A E2F4 TGFB1 IGF1R HDAC1 | 2.38e-05 | 313 | 208 | 13 | int:HDAC3 |
| Interaction | ARHGAP32 interactions | 2.51e-05 | 149 | 208 | 9 | int:ARHGAP32 | |
| Interaction | PLEKHA5 interactions | EPHB2 EPHB6 SRPK2 VCL PLEKHA6 RHOA RHOB IGF1R WASH2P CDH1 HDAC1 | 2.96e-05 | 231 | 208 | 11 | int:PLEKHA5 |
| Interaction | ADGRL2 interactions | 3.04e-05 | 86 | 208 | 7 | int:ADGRL2 | |
| Interaction | TJP1 interactions | CEP104 RBM26 ACTN1 CUL7 TAOK2 ZPR1 VCL DTNA CNTRL RHOA RHOB MARVELD2 CDH1 | 3.52e-05 | 325 | 208 | 13 | int:TJP1 |
| Interaction | PEAK1 interactions | 3.79e-05 | 157 | 208 | 9 | int:PEAK1 | |
| Interaction | NPHS2 interactions | 5.12e-05 | 64 | 208 | 6 | int:NPHS2 | |
| Interaction | RAPH1 interactions | 5.12e-05 | 64 | 208 | 6 | int:RAPH1 | |
| Interaction | SNAI3 interactions | 5.84e-05 | 8 | 208 | 3 | int:SNAI3 | |
| Interaction | ZNF521 interactions | 6.18e-05 | 41 | 208 | 5 | int:ZNF521 | |
| Interaction | CTNNA1 interactions | RBM26 ACTN1 CUL7 VCL DTNA E2F4 PLEKHA6 RHOA RHOB RHOC CDH1 CDH3 EPHA4 | 6.87e-05 | 347 | 208 | 13 | int:CTNNA1 |
| Interaction | EHD2 interactions | 7.85e-05 | 69 | 208 | 6 | int:EHD2 | |
| Interaction | RBM15 interactions | 8.79e-05 | 175 | 208 | 9 | int:RBM15 | |
| Interaction | NCK2 interactions | 9.21e-05 | 262 | 208 | 11 | int:NCK2 | |
| Interaction | CDH2 interactions | 9.97e-05 | 139 | 208 | 8 | int:CDH2 | |
| Interaction | NHS interactions | 1.33e-04 | 48 | 208 | 5 | int:NHS | |
| Interaction | USP6NL interactions | 1.46e-04 | 110 | 208 | 7 | int:USP6NL | |
| Interaction | EPS8L1 interactions | 1.47e-04 | 49 | 208 | 5 | int:EPS8L1 | |
| Interaction | ARHGEF15 interactions | 1.47e-04 | 49 | 208 | 5 | int:ARHGEF15 | |
| Interaction | YES1 interactions | EPHB2 MYCN FUNDC1 CUL7 DHX15 NPHS1 IKZF3 RHOA RHOB RHOC IL1R1 CDH1 PCDHGC3 | 1.49e-04 | 375 | 208 | 13 | int:YES1 |
| Interaction | RAB9A interactions | DENND4A HLCS EXOC3 CUL7 PLXNB2 PLEKHM2 WASHC5 DOP1B ABI1 CALU CNTRL SHB RHOA RHOB RHOC CRYBG3 SMCR8 | 1.56e-04 | 595 | 208 | 17 | int:RAB9A |
| Interaction | HR interactions | 1.62e-04 | 50 | 208 | 5 | int:HR | |
| Interaction | JUP interactions | EPHB2 MYCN ACTN1 CUL7 PTPRK VCL RHOA RHOB RHOC IGF1R CDH1 CDH3 HDAC1 HDAC2 EPHA4 | 1.64e-04 | 485 | 208 | 15 | int:JUP |
| Interaction | INSM1 interactions | 1.68e-04 | 11 | 208 | 3 | int:INSM1 | |
| Interaction | MAD1L1 interactions | 1.69e-04 | 150 | 208 | 8 | int:MAD1L1 | |
| Interaction | MSN interactions | EPHB2 DHX15 VCL ISYNA1 CALU CNTRL E2F4 RHOA RHOB IGF1R ENO1 HDAC2 | 1.72e-04 | 330 | 208 | 12 | int:MSN |
| Interaction | EPHA2 interactions | EPHB2 EPHB6 EPHA6 EXOC3 PLXNB2 F3 GLB1 ABI1 DTNA SHB PLEKHA6 TGFB1 RHOA RHOB RHOC IGF1R ABI2 CDH1 EPHA4 | 1.75e-04 | 719 | 208 | 19 | int:EPHA2 |
| Interaction | SRC interactions | EPHB2 SRPK2 ACTN1 PGR HDAC3 VCL NPHS1 SH3BP2 SHB E2F4 TAMALIN RHOB IGF1R IL1R1 ENO1 CDH1 PCDHGC3 EPHA4 | 1.91e-04 | 664 | 208 | 18 | int:SRC |
| Interaction | DGKG interactions | 2.14e-04 | 29 | 208 | 4 | int:DGKG | |
| Interaction | OVOL1 interactions | 2.23e-04 | 12 | 208 | 3 | int:OVOL1 | |
| Interaction | UNC5B interactions | 2.34e-04 | 84 | 208 | 6 | int:UNC5B | |
| Interaction | SLC16A1 interactions | 2.41e-04 | 200 | 208 | 9 | int:SLC16A1 | |
| Interaction | CALM3 interactions | EPHB2 EPHB6 DENND4A EPHA6 RBM26 CUL7 PHKA1 PLCB3 FLNB PPEF1 IGF1R EPHA4 | 2.46e-04 | 343 | 208 | 12 | int:CALM3 |
| Interaction | PKP4 interactions | 2.52e-04 | 159 | 208 | 8 | int:PKP4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE13 SPDYE15 SPDYE14 SPDYE17 SPDYE10 SPDYE9 CASTOR2 SPDYE12 SPDYE8 | 9.48e-07 | 271 | 222 | 10 | chr7q11 |
| Cytoband | 7q11.23 | 1.13e-04 | 97 | 222 | 5 | 7q11.23 | |
| Cytoband | 1p36.21 | 2.53e-04 | 63 | 222 | 4 | 1p36.21 | |
| GeneFamily | Fibronectin type III domain containing | 4.45e-07 | 160 | 139 | 10 | 555 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.77e-06 | 4 | 139 | 3 | 989 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.15e-06 | 14 | 139 | 4 | 1095 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.95e-04 | 206 | 139 | 8 | 682 | |
| GeneFamily | Rho family GTPases | 4.61e-04 | 20 | 139 | 3 | 390 | |
| GeneFamily | CD molecules|Type I classical cadherins | 5.78e-04 | 5 | 139 | 2 | 1185 | |
| GeneFamily | Glycine receptors | 5.78e-04 | 5 | 139 | 2 | 868 | |
| GeneFamily | Sterile alpha motif domain containing | 5.87e-04 | 88 | 139 | 5 | 760 | |
| GeneFamily | PRAME family | 8.00e-04 | 24 | 139 | 3 | 686 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.04e-03 | 9 | 139 | 2 | 973 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 2.04e-03 | 9 | 139 | 2 | 1306 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.68e-03 | 12 | 139 | 2 | 1243 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.68e-03 | 12 | 139 | 2 | 756 | |
| GeneFamily | PHD finger proteins|NuRD complex | 3.68e-03 | 12 | 139 | 2 | 1305 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 5.77e-03 | 15 | 139 | 2 | 696 | |
| Coexpression | TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 SH3BP2 RHOB RHOC LTA4H | 3.08e-07 | 180 | 215 | 11 | M41701 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 KDM4C SRPK2 F3 DHX15 FAT1 ATP11B PTPRK ST3GAL5 VCL DOP1B FLNB STRN3 SCHIP1 ABI1 SHB MYOF IBTK IGF1R FAM169A CRYBG3 IL1R1 EPHA4 | 6.70e-07 | 856 | 215 | 23 | M4500 |
| Coexpression | GSE3982_DC_VS_TH1_UP | SPI1 SRPK2 PLXNB2 ROBO3 TRAPPC9 VCL CORO2A MYOF CRYBG3 FBXO21 | 6.48e-06 | 200 | 215 | 10 | M5481 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SRPK2 F3 DHX15 FAT1 ATP11B PTPRK DOP1B FLNB STRN3 SCHIP1 ABI1 SHB IBTK FAM169A EPHA4 | 7.88e-06 | 466 | 215 | 15 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | TENM2 RYR3 FAT1 IQCJ-SCHIP1 SPAG16 NPHS1 DPP6 SGIP1 IGF1R P3H2 | 1.08e-05 | 212 | 215 | 10 | M39221 |
| Coexpression | MASSARWEH_RESPONSE_TO_ESTRADIOL | 1.19e-05 | 62 | 215 | 6 | M14447 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 RBM26 DNER LYST TENM2 FSIP2 PTPRK ST3GAL5 SCN9A GNAL DOP1B DPP6 CACNB4 COL11A1 IKZF3 NXPH1 APBA1 PLEKHA6 PRKAA2 RASGEF1B FAM169A RIMBP2 UBASH3B PRLR | 1.47e-05 | 1106 | 215 | 24 | M39071 |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN | 3.55e-05 | 195 | 215 | 9 | M8142 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 4.33e-05 | 200 | 215 | 9 | M5276 | |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 4.33e-05 | 200 | 215 | 9 | M7962 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_DN | 5.42e-05 | 256 | 215 | 10 | M828 | |
| Coexpression | BECKER_TAMOXIFEN_RESISTANCE_DN | 8.08e-05 | 54 | 215 | 5 | M15676 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | MYCN PRAMEF5 GFRA2 GFRA3 SHD PCNX2 SPAG16 PRAMEF11 PRAMEF6 DPP6 ISYNA1 KCP CLIC6 MARVELD2 ARHGAP27 | 8.63e-05 | 574 | 215 | 15 | MM820 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | PGR FAT1 ATP11B PTPRK CACNB4 DTNA GLRA3 DGKD PSTPIP2 AREG IGF1R RCBTB1 DNAJC15 PCSK6 FAM169A PATJ PRLR EPHA4 | 9.25e-05 | 786 | 215 | 18 | M10961 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST | 1.07e-04 | 131 | 215 | 7 | M1687 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN | 1.21e-04 | 179 | 215 | 8 | M4259 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | MYCN PYY PPP2R3B FTCD HOXA1 MAPK8IP1 FLNB AREG RHOB MYOF CDH1 FGD6 RCN3 | 1.22e-04 | 461 | 215 | 13 | M14127 |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN | 1.29e-04 | 135 | 215 | 7 | M6759 | |
| Coexpression | DESCARTES_ORGANOGENESIS_NOTOCHORD_CELLS | 1.45e-04 | 61 | 215 | 5 | MM3633 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.46e-04 | 184 | 215 | 8 | M8544 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | F3 HOXA1 SMPDL3B GNAL FLNB CORO2A PSTPIP2 AREG P3H2 FAM169A CDH1 CDH3 FGD6 | 1.57e-04 | 473 | 215 | 13 | M4306 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST | 1.62e-04 | 140 | 215 | 7 | MM1211 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.70e-04 | 188 | 215 | 8 | MM983 | |
| Coexpression | AIGNER_ZEB1_TARGETS | 1.89e-04 | 35 | 215 | 4 | M14590 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 1.96e-04 | 192 | 215 | 8 | M2317 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.97e-04 | 244 | 215 | 9 | M40312 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 2.10e-04 | 194 | 215 | 8 | MM910 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 2.10e-04 | 194 | 215 | 8 | M2081 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_DN | 2.17e-04 | 195 | 215 | 8 | M4516 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN | 2.35e-04 | 37 | 215 | 4 | M12678 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN | 2.35e-04 | 37 | 215 | 4 | MM785 | |
| Coexpression | GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 2.50e-04 | 199 | 215 | 8 | M8551 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN | 2.50e-04 | 199 | 215 | 8 | M8641 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN | 2.50e-04 | 199 | 215 | 8 | M9283 | |
| Coexpression | GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP | 2.58e-04 | 200 | 215 | 8 | M363 | |
| Coexpression | GSE27786_NKCELL_VS_ERYTHROBLAST_UP | 2.58e-04 | 200 | 215 | 8 | M4853 | |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP | 2.58e-04 | 200 | 215 | 8 | M9689 | |
| Coexpression | GSE17580_TREG_VS_TEFF_DN | 2.58e-04 | 200 | 215 | 8 | M3671 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 2.58e-04 | 200 | 215 | 8 | M6242 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN | 2.58e-04 | 200 | 215 | 8 | M6624 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN | 2.58e-04 | 200 | 215 | 8 | M7822 | |
| Coexpression | GSE3982_DC_VS_BASOPHIL_UP | 2.58e-04 | 200 | 215 | 8 | M5472 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_DN | 2.58e-04 | 200 | 215 | 8 | M5674 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | EPHB2 SPI1 PLXNB2 LYST SLC24A4 GLB1 ST3GAL5 C2 UNC93B1 FGD2 ATG7 SH3BP2 PSTPIP2 RHOB MYOF MFSD2A RASGEF1B ARHGAP27 KDM1B FGD6 | 2.71e-04 | 1012 | 215 | 20 | M40868 |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | PHKA1 ST3GAL5 COL11A1 CORO2A CLIC6 MFSD2A P3H2 PRKAA2 RIMBP2 PATJ CDH1 CDH3 LRRC36 | 9.67e-12 | 187 | 218 | 13 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | SMPDL3B ST3GAL5 COL11A1 CORO2A CLIC6 AREG P3H2 RIMBP2 PATJ CDH1 CDH3 PRLR LRRC36 | 1.18e-11 | 190 | 218 | 13 | 625c08a0e5227efc46daa512fd579c3938ff76c7 |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 SH3BP2 PSTPIP2 RHOC MYOF RASGEF1B KDM1B | 2.26e-11 | 200 | 218 | 13 | 334bab6bf93d455f3526e817ea5785d8b6ee531c |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF KDM1B | 3.02e-10 | 198 | 218 | 12 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 |
| ToppCell | severe-Non-classical_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SPI1 PLXNB2 ST3GAL5 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 3.40e-10 | 200 | 218 | 12 | 6cc7190a4ffc6c06335072f3b5b5f98eae36e2ce |
| ToppCell | Control-Control-Myeloid-CD16+_Monocyte|Control / Disease, condition lineage and cell class | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF KDM1B | 3.40e-10 | 200 | 218 | 12 | 8dd124a5aca897652ea68efbfc5a167b4cf31aef |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | MYCN SMPDL3B COL11A1 CLIC6 P3H2 RIMBP2 MARVELD2 PATJ CDH1 CDH3 LRRC36 | 3.05e-09 | 192 | 218 | 11 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | MYCN SMPDL3B IQCJ-SCHIP1 COL11A1 CLIC6 P3H2 RIMBP2 MARVELD2 CDH1 CDH3 LRRC36 | 3.22e-09 | 193 | 218 | 11 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EPHA6 BMP3 SCN9A CLIC6 P3H2 RIMBP2 MARVELD2 PATJ CDH1 CDH3 LRRC36 | 3.40e-09 | 194 | 218 | 11 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ST3GAL5 IQCJ-SCHIP1 COL11A1 CLIC6 AREG MFSD2A P3H2 RIMBP2 CDH1 CDH3 LRRC36 | 3.40e-09 | 194 | 218 | 11 | c47fc3f716ab091a39c20d7639ac783029589ee5 |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | BMP3 ST3GAL5 COL11A1 CLIC6 P3H2 PRKAA2 RIMBP2 PATJ CDH1 CDH3 LRRC36 | 3.78e-09 | 196 | 218 | 11 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | 083fec147040ee0bebac2815fb89355cf3a7ffa5 |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | b82142cf8057a55dfa884248b752173661edffd1 |
| ToppCell | COVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 3.99e-09 | 197 | 218 | 11 | c5837b9a5a39a0f607a4e217ade9fc87d82a5406 |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | 70faaea9c143337a52c8f660ebb063aa92327357 |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | 422074930fce25a6ad15ba41e391c65787e7878e |
| ToppCell | 11.5-Distal-Epithelial|Distal / Age, Tissue, Lineage and Cell class | BMP3 SMPDL3B ST3GAL5 COL11A1 CLIC6 MFSD2A P3H2 CDH1 CDH3 LRRC36 PRODH | 3.99e-09 | 197 | 218 | 11 | ae9505ae7e6c5e8c280f9bfb1ba79ab5bd8895e3 |
| ToppCell | COVID-19_Mild-Myeloid-Non-classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | 9c943d18f8e6cb0ce9f2158d50796fafae5c81d4 |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | f0e6745b0fd734ea17e7a2a883e48017e8d3102d |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | SPI1 PLXNB2 ST3GAL5 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 3.99e-09 | 197 | 218 | 11 | 368644260f70895052a1d71171a9d882315354dd |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 3.99e-09 | 197 | 218 | 11 | 96d56bce69de7192c7a6b43371b56f4acdcc7733 |
| ToppCell | 15-Distal-Epithelial|Distal / Age, Tissue, Lineage and Cell class | BMP3 SMPDL3B ST3GAL5 ISYNA1 COL11A1 CLIC6 MFSD2A P3H2 PATJ CDH1 PRODH | 3.99e-09 | 197 | 218 | 11 | 9fbd1abf050b364155a67962a9731118304f72fb |
| ToppCell | 15-Distal-Epithelial-Bud_tip_adjacent|Distal / Age, Tissue, Lineage and Cell class | BMP3 SMPDL3B ST3GAL5 ISYNA1 CLIC6 P3H2 TMC5 PATJ CDH1 CDH3 PRODH | 4.21e-09 | 198 | 218 | 11 | f4d9d5995a42f71bf412f0ad299fc963bad3a898 |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | BMP3 ST3GAL5 COL11A1 CLIC6 AREG MFSD2A P3H2 RIMBP2 CDH1 CDH3 LRRC36 | 4.21e-09 | 198 | 218 | 11 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | 3bc3dbd178043deadd7eef413b2761dc003abd6e |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.21e-09 | 198 | 218 | 11 | d36a3cda7e5f385d2391e9b0dfb027d3c4549320 |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.21e-09 | 198 | 218 | 11 | 5436c3ed16e10e00c686f1ab0b0a68728a1a9985 |
| ToppCell | Healthy-Non-classical_Monocyte|World / disease group, cell group and cell class | SPI1 PLXNB2 LYST PRAM1 SLC24A4 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 4.21e-09 | 198 | 218 | 11 | 4fd27a9fb3758c94ed9f0a726296e92b0625da44 |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.21e-09 | 198 | 218 | 11 | 4f67067d8142ca11b2d80195dac8d62a8d24d52c |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.21e-09 | 198 | 218 | 11 | 9b8679b3dd8f4220d71f607b7080cb88d6e71129 |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.21e-09 | 198 | 218 | 11 | 8b6b602ebe59b6dca6a22f17385d3160ff3ac67e |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | SPI1 PLXNB2 PRAM1 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | d7620b8d24e04ce1c563fc0ebe1625e03fe78950 |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.21e-09 | 198 | 218 | 11 | b9030390316baf456135f85f831394e1e11ecf3e |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | 8b5d30312bbcabc6911ff03e5028766d77203dff |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | ae0a51e63e2751a6d9dc0c8a3852680949173523 |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | 7d8fade2583c07a33dd83057cbce08e9fc77987a |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | SPI1 PLXNB2 SLC24A4 ST3GAL5 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPI1 PLXNB2 LYST PRAM1 SLC24A4 UNC93B1 FGD2 RHOB RHOC MYOF KDM1B | 4.21e-09 | 198 | 218 | 11 | 165d60b111a17d517a420c434733eefb98da240d |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class | SPI1 PLXNB2 C2 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF RASGEF1B KDM1B | 4.67e-09 | 200 | 218 | 11 | 58fbb7fc7159cbc417e6b457d60b7beba9b90da6 |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD16+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | SPI1 PLXNB2 PRAM1 UNC93B1 FGD2 SH3BP2 RHOB RHOC MYOF LTA4H KDM1B | 4.67e-09 | 200 | 218 | 11 | 5c0eb14bdf1bfeaf93f6c3d521529bd5a4de50ce |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SPI1 PLXNB2 LYST PRAM1 UNC93B1 FGD2 RHOB RHOC MYOF LTA4H KDM1B | 4.67e-09 | 200 | 218 | 11 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | ST3GAL5 ISYNA1 COL11A1 CLIC6 MFSD2A P3H2 PATJ ENO1 CDH1 CDH3 LRRC36 | 4.67e-09 | 200 | 218 | 11 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.65e-08 | 175 | 218 | 10 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-08 | 182 | 218 | 10 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.95e-08 | 186 | 218 | 10 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | BMP3 ST3GAL5 COL11A1 CORO2A CLIC6 P3H2 MARVELD2 CDH1 CDH3 LRRC36 | 3.10e-08 | 187 | 218 | 10 | c2940aec30b3c2c113f6a65126dc6f1969cf301e |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-08 | 189 | 218 | 10 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.98e-08 | 192 | 218 | 10 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | F3 IQCJ-SCHIP1 COL11A1 CLIC6 AREG MFSD2A P3H2 CDH1 CDH3 LRRC36 | 3.98e-08 | 192 | 218 | 10 | 39804d9ddc67c1b41887752df2503389eae44a1a |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | COL11A1 CORO2A CLIC6 AREG P3H2 RIMBP2 MARVELD2 CDH1 CDH3 LRRC36 | 3.98e-08 | 192 | 218 | 10 | 1aa5e4d9b32013a3f272561dcb8377f6805706df |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-08 | 193 | 218 | 10 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 4.39e-08 | 194 | 218 | 10 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | BMP3 ST3GAL5 COL11A1 CLIC6 MFSD2A P3H2 PRKAA2 CDH1 CDH3 LRRC36 | 4.39e-08 | 194 | 218 | 10 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | SPI1 PLXNB2 PRAM1 SLC24A4 C2 SH3BP2 RHOC MYOF RASGEF1B KDM1B | 4.84e-08 | 196 | 218 | 10 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class | 4.84e-08 | 196 | 218 | 10 | 8ef9810ee99082a9c803c7ecad6ceb5710d16b54 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ST3GAL5 COL11A1 CLIC6 MFSD2A P3H2 RIMBP2 PATJ CDH1 CDH3 LRRC36 | 4.84e-08 | 196 | 218 | 10 | 0a34a0009f479384f1994c6f977f942699a132c8 |
| ToppCell | (001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 4.84e-08 | 196 | 218 | 10 | 33843d550cbca03c044d593b1f6972e4d3871f7f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.84e-08 | 196 | 218 | 10 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ST3GAL5 IQCJ-SCHIP1 COL11A1 CLIC6 MFSD2A P3H2 RIMBP2 CDH1 CDH3 LRRC36 | 5.07e-08 | 197 | 218 | 10 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 5.07e-08 | 197 | 218 | 10 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | SPI1 PLXNB2 PRAM1 ST3GAL5 UNC93B1 SH3BP2 RHOB RHOC MYOF KDM1B | 5.32e-08 | 198 | 218 | 10 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 |
| ToppCell | severe_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 5.32e-08 | 198 | 218 | 10 | 790ee20abc9666b8095675b0d445c0914ee70ea3 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | SPI1 PLXNB2 SLC24A4 ST3GAL5 C2 FGD2 SH3BP2 MYOF RASGEF1B KDM1B | 5.32e-08 | 198 | 218 | 10 | 8449934e20bb2a34079fb642cae0d4647b9efe51 |
| ToppCell | Healthy/Control-Non-classical_Monocyte|Healthy/Control / Disease group and Cell class | 5.32e-08 | 198 | 218 | 10 | 0badaf1fa5328d06291c3624d0f63196ffc81527 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-CD16+_Monocyte|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.85e-08 | 200 | 218 | 10 | add2f9fbada3a68662edc8c756af90cdc380295b | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-CD16+_Monocyte|Influenza_Severe / Disease, condition lineage and cell class | 5.85e-08 | 200 | 218 | 10 | 1efdcfcd86e99fbe03db19a2a5ab10808eec282d | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 9.46e-08 | 159 | 218 | 9 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.46e-08 | 159 | 218 | 9 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 1.37e-07 | 166 | 218 | 9 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-07 | 168 | 218 | 9 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-07 | 171 | 218 | 9 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-07 | 175 | 218 | 9 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-07 | 180 | 218 | 9 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-07 | 182 | 218 | 9 | 1e2149b222a3e9f64841aed45288a6f29394e7b0 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.13e-07 | 183 | 218 | 9 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-07 | 184 | 218 | 9 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-07 | 184 | 218 | 9 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.43e-07 | 185 | 218 | 9 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.59e-07 | 186 | 218 | 9 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-07 | 186 | 218 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 187 | 218 | 9 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 187 | 218 | 9 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.92e-07 | 188 | 218 | 9 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 189 | 218 | 9 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 189 | 218 | 9 | a6c62b456982067ad4d224a2efa3919969000693 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 189 | 218 | 9 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 4.29e-07 | 190 | 218 | 9 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 4.48e-07 | 191 | 218 | 9 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.48e-07 | 191 | 218 | 9 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.68e-07 | 192 | 218 | 9 | 8898332387e5d746feb346ce1dabd6b2218fc6e5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.68e-07 | 192 | 218 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 4.68e-07 | 192 | 218 | 9 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.68e-07 | 192 | 218 | 9 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.89e-07 | 193 | 218 | 9 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-07 | 193 | 218 | 9 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-07 | 193 | 218 | 9 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-07 | 194 | 218 | 9 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.11e-07 | 194 | 218 | 9 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| Drug | trapoxin | 1.14e-06 | 58 | 213 | 7 | CID000121875 | |
| Drug | sevoflurane | 6.59e-06 | 105 | 213 | 8 | CID000005206 | |
| Drug | Vorinostat | 7.96e-06 | 5 | 213 | 3 | DB02546 | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.40e-05 | 192 | 213 | 10 | 6808_DN | |
| Drug | Rodeo | 1.61e-05 | 17 | 213 | 4 | CID000038078 | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.68e-05 | 196 | 213 | 10 | 5604_DN | |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | EPHB2 RBM26 PLCB3 DOP1B MAP3K8 CNTRL PBRM1 FAM169A PATJ MYBPC3 | 1.75e-05 | 197 | 213 | 10 | 7358_UP |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | ST3GAL5 LTBP4 TRAPPC9 LAMB4 APBA1 GLRA3 PCSK6 CEP41 RIMBP2 ACSL5 | 1.75e-05 | 197 | 213 | 10 | 3616_UP |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 1.75e-05 | 197 | 213 | 10 | 3737_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.75e-05 | 197 | 213 | 10 | 3247_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; PC3; HT_HG-U133A | 1.75e-05 | 197 | 213 | 10 | 5106_DN | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.83e-05 | 198 | 213 | 10 | 1340_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.91e-05 | 199 | 213 | 10 | 2802_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.91e-05 | 199 | 213 | 10 | 2135_DN | |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | EPHB2 KDM4C HLCS BMP3 ST3GAL5 CAMSAP1 LAMB4 PCSK6 RAB40C PRODH | 1.91e-05 | 199 | 213 | 10 | 7216_UP |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | TRPM4 CAMSAP1 COPA DTNA CNTRL PSTPIP2 RCBTB1 PCSK6 FAM169A RCN3 | 1.91e-05 | 199 | 213 | 10 | 7348_UP |
| Drug | Boc-glycine | 2.75e-05 | 7 | 213 | 3 | CID000078288 | |
| Drug | N-Sb | 3.21e-05 | 20 | 213 | 4 | CID000030837 | |
| Drug | LG100268 | 4.58e-05 | 69 | 213 | 6 | CID000003922 | |
| Drug | etomidate | 5.39e-05 | 71 | 213 | 6 | CID000036339 | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; HL60; HT_HG-U133A | 5.67e-05 | 182 | 213 | 9 | 3142_UP | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 7.28e-05 | 188 | 213 | 9 | 974_UP | |
| Drug | exoenzyme C3, Clostridium botulinum | 8.07e-05 | 25 | 213 | 4 | ctd:C063007 | |
| Drug | propofol | 8.22e-05 | 191 | 213 | 9 | CID000004943 | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 8.56e-05 | 192 | 213 | 9 | 1076_UP | |
| Drug | 2-methyl-5-(1-methylethenyl)cyclohexanol | 8.71e-05 | 2 | 213 | 2 | ctd:C534305 | |
| Drug | nitrobenzenediazonium fluoroborate | 8.71e-05 | 2 | 213 | 2 | CID000173205 | |
| Drug | propanethiol | 8.71e-05 | 2 | 213 | 2 | ctd:C030762 | |
| Drug | perillic acid | 8.71e-05 | 2 | 213 | 2 | ctd:C078706 | |
| Drug | cytotoxic necrotizing factor type 1 | 8.71e-05 | 2 | 213 | 2 | ctd:C060296 | |
| Drug | Pimelic Acids | 8.71e-05 | 2 | 213 | 2 | ctd:D010867 | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 8.90e-05 | 193 | 213 | 9 | 948_UP | |
| Drug | CI-994 | 9.23e-05 | 10 | 213 | 3 | CID000002746 | |
| Drug | Br-coeleneterazine | 9.23e-05 | 10 | 213 | 3 | CID005288010 | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 9.26e-05 | 194 | 213 | 9 | 5049_DN | |
| Drug | ciglitazone | 9.62e-05 | 241 | 213 | 10 | ctd:C039671 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.63e-05 | 195 | 213 | 9 | 4345_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.00e-04 | 196 | 213 | 9 | 6354_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 4137_DN | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 2821_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 4754_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 6863_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 3867_UP | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 5274_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 3528_DN | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.04e-04 | 197 | 213 | 9 | 7253_UP | |
| Drug | sodium bisulfite | 1.04e-04 | 154 | 213 | 8 | CID000024437 | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 213 | 9 | 6096_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 213 | 9 | 5422_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 213 | 9 | 2708_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 213 | 9 | 5295_UP | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 213 | 9 | 1489_UP | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; PC3; HT_HG-U133A | 1.08e-04 | 198 | 213 | 9 | 4221_UP | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 155 | 213 | 8 | 6817_DN | |
| Drug | C13H9cl2NO5 | 1.10e-04 | 27 | 213 | 4 | CID004369477 | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 199 | 213 | 9 | 3264_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | 1.12e-04 | 199 | 213 | 9 | 3675_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 200 | 213 | 9 | 6246_UP | |
| Drug | vinylidene chloride | DENND4A FTCD F3 LYST FAT1 SMPDL3B GLB1 ST3GAL5 VNN1 C2 VCL NPHS1 CACNB4 MAP3K8 SH3BP2 CLIC6 AREG CCNA2 RHOC MYOF MFSD2A P3H2 PRKAA2 KDM1B PATJ FBXO21 FGD6 PRLR EPHA4 | 1.22e-04 | 1475 | 213 | 29 | ctd:C029297 |
| Drug | ip 0 | 1.26e-04 | 11 | 213 | 3 | CID000006943 | |
| Drug | AC1L9IH9 | 1.26e-04 | 11 | 213 | 3 | CID000445730 | |
| Disease | ulcerative colitis (implicated_via_orthology) | 8.10e-08 | 7 | 207 | 4 | DOID:8577 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | MBD1 SYNPO2L PYY PLXNB2 DHX15 PLEKHM2 IQCJ-SCHIP1 ROBO3 TRAPPC9 VCL PTCD3 FLNB COL11A1 SGIP1 ATG7 CNTRL SHB CCNA2 TGFB1 PBRM1 ABI2 HHIPL1 FGD6 CDH17 MYBPC3 | 1.66e-05 | 1392 | 207 | 25 | EFO_0005763 |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 1.86e-05 | 8 | 207 | 3 | DOID:0080377 (implicated_via_orthology) | |
| Disease | Agouti-related protein measurement | 3.64e-05 | 27 | 207 | 4 | EFO_0008016 | |
| Disease | alopecia areata (is_marker_for) | 3.94e-05 | 10 | 207 | 3 | DOID:986 (is_marker_for) | |
| Disease | hyperprolactinemia (is_implicated_in) | 4.90e-05 | 2 | 207 | 2 | DOID:12700 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | EPHB2 RBM26 LYST TENM2 REXO1 SLC24A4 IQCJ-SCHIP1 PCSK6 RASGEF1B RIMBP2 UNC13C PATJ | 8.26e-05 | 447 | 207 | 12 | EFO_0000694, MONDO_0100096 |
| Disease | Left ventricular noncompaction | 1.17e-04 | 14 | 207 | 3 | C1960469 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.26e-04 | 69 | 207 | 5 | DOID:4450 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 1.27e-04 | 157 | 207 | 7 | DOID:9256 (is_marker_for) | |
| Disease | diabetes mellitus (is_marker_for) | 1.94e-04 | 41 | 207 | 4 | DOID:9351 (is_marker_for) | |
| Disease | Squamous cell carcinoma | 2.49e-04 | 124 | 207 | 6 | C0007137 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.74e-04 | 195 | 207 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | soluble transferrin receptor measurement, iron biomarker measurement | 4.83e-04 | 5 | 207 | 2 | EFO_0004460, EFO_0004461 | |
| Disease | spine bone mineral density change measurement, response to combination chemotherapy | 4.83e-04 | 5 | 207 | 2 | EFO_0007965, EFO_0008474 | |
| Disease | cognitive function measurement | DENND4A KDM4C SRPK2 PLXNB2 GFRA2 RYR3 DHX15 CCDC66 C2 IQCJ-SCHIP1 SPAG16 WNK2 COL11A1 CALU APBA1 RHOA PCSK6 RIMBP2 PRLR CDH17 ACSL5 MYBPC3 | 5.02e-04 | 1434 | 207 | 22 | EFO_0008354 |
| Disease | Muscular Dystrophy, Duchenne | 7.21e-04 | 6 | 207 | 2 | C0013264 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 9.60e-04 | 160 | 207 | 6 | DOID:5844 (biomarker_via_orthology) | |
| Disease | ovarian carcinoma (is_marker_for) | 9.79e-04 | 28 | 207 | 3 | DOID:4001 (is_marker_for) | |
| Disease | Endometrioma | 9.91e-04 | 161 | 207 | 6 | C0269102 | |
| Disease | Endometriosis | 9.91e-04 | 161 | 207 | 6 | C0014175 | |
| Disease | Writer's Cramp | 1.00e-03 | 7 | 207 | 2 | C4316810 | |
| Disease | Dystonia Disorders | 1.00e-03 | 7 | 207 | 2 | C0393593 | |
| Disease | Idiopathic familial dystonia | 1.00e-03 | 7 | 207 | 2 | C0393598 | |
| Disease | Adult-Onset Idiopathic Focal Dystonias | 1.00e-03 | 7 | 207 | 2 | C0752198 | |
| Disease | Adult-Onset Dystonias | 1.00e-03 | 7 | 207 | 2 | C0752197 | |
| Disease | Adult-Onset Idiopathic Torsion Dystonias | 1.00e-03 | 7 | 207 | 2 | C0752199 | |
| Disease | Autosomal Dominant Familial Dystonia | 1.00e-03 | 7 | 207 | 2 | C0752200 | |
| Disease | Childhood Onset Dystonias | 1.00e-03 | 7 | 207 | 2 | C0752202 | |
| Disease | Autosomal Recessive Familial Dystonia | 1.00e-03 | 7 | 207 | 2 | C0752201 | |
| Disease | Dystonia, Primary | 1.00e-03 | 7 | 207 | 2 | C0752203 | |
| Disease | Dystonias, Sporadic | 1.00e-03 | 7 | 207 | 2 | C0752206 | |
| Disease | Dystonia, Secondary | 1.00e-03 | 7 | 207 | 2 | C0752205 | |
| Disease | Pseudodystonia | 1.00e-03 | 7 | 207 | 2 | C0752208 | |
| Disease | Familial Dystonia | 1.00e-03 | 7 | 207 | 2 | C0752207 | |
| Disease | Focal Dystonia | 1.00e-03 | 7 | 207 | 2 | C0743332 | |
| Disease | Carcinomatosis | 1.06e-03 | 163 | 207 | 6 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.06e-03 | 163 | 207 | 6 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.06e-03 | 163 | 207 | 6 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.06e-03 | 163 | 207 | 6 | C0205696 | |
| Disease | pulmonary hypertension (is_marker_for) | 1.08e-03 | 64 | 207 | 4 | DOID:6432 (is_marker_for) | |
| Disease | Carcinoma | 1.09e-03 | 164 | 207 | 6 | C0007097 | |
| Disease | response to angiotensin receptor blocker | 1.20e-03 | 30 | 207 | 3 | EFO_0010735 | |
| Disease | Liver Cirrhosis, Experimental | LGMN ACTN1 FTCD FAT1 UNC93B1 ISYNA1 MAP3K8 PSTPIP1 CCNA2 TGFB1 LTA4H PRLR PRODH SEZ6 | 1.21e-03 | 774 | 207 | 14 | C0023893 |
| Disease | biological sex | 1.25e-03 | 230 | 207 | 7 | PATO_0000047 | |
| Disease | COVID-19, mortality | 1.31e-03 | 170 | 207 | 6 | EFO_0004352, MONDO_0100096 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 1.33e-03 | 8 | 207 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 1.33e-03 | 8 | 207 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | neurexophilin-1 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0008244 | |
| Disease | Prostate cancer, familial | 1.42e-03 | 69 | 207 | 4 | C2931456 | |
| Disease | Nonorganic psychosis | 1.42e-03 | 69 | 207 | 4 | C0349204 | |
| Disease | Malignant neoplasm of breast | HLCS F3 PGR HOXB13 FLNB COL11A1 TMPRSS6 MTMR8 AREG IGF1R PBRM1 TXNDC15 P3H2 PRKAA2 ENO1 CDH1 PRODH | 1.58e-03 | 1074 | 207 | 17 | C0006142 |
| Disease | cholesteryl ester 18:2 measurement | 1.59e-03 | 33 | 207 | 3 | EFO_0010345 | |
| Disease | internet addiction disorder | 1.59e-03 | 33 | 207 | 3 | EFO_0803368 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.67e-03 | 72 | 207 | 4 | DOID:9744 (is_marker_for) | |
| Disease | Pulmonary Cystic Fibrosis | 1.71e-03 | 9 | 207 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 1.71e-03 | 9 | 207 | 2 | C1527396 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 1.73e-03 | 34 | 207 | 3 | DOID:9952 (is_marker_for) | |
| Disease | left ventricular mass index | 1.73e-03 | 34 | 207 | 3 | EFO_0009290 | |
| Disease | Ovarian Cysts | 1.89e-03 | 35 | 207 | 3 | C0029927 | |
| Disease | Autoinflammatory disorder | 1.89e-03 | 35 | 207 | 3 | C3860213 | |
| Disease | Corpus Luteum Cyst | 1.89e-03 | 35 | 207 | 3 | C0010093 | |
| Disease | Neoplasm Invasiveness | 1.96e-03 | 184 | 207 | 6 | C0027626 | |
| Disease | breast cancer (is_marker_for) | 2.01e-03 | 185 | 207 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Asthma, Occupational | 2.12e-03 | 10 | 207 | 2 | C0264423 | |
| Disease | Lung diseases | 2.24e-03 | 78 | 207 | 4 | C0024115 | |
| Disease | total iron binding capacity | 2.24e-03 | 78 | 207 | 4 | EFO_0006334 | |
| Disease | lip morphology measurement | 2.24e-03 | 189 | 207 | 6 | EFO_0007845 | |
| Disease | Tinnitus | 2.28e-03 | 130 | 207 | 5 | HP_0000360 | |
| Disease | aspirin use measurement | 2.58e-03 | 39 | 207 | 3 | EFO_0007013 | |
| Disease | Cystic Fibrosis | 2.58e-03 | 11 | 207 | 2 | C0010674 | |
| Disease | Inherited neuropathies | 2.78e-03 | 40 | 207 | 3 | C0598589 | |
| Disease | apolipoprotein A 1 measurement | SPI1 F3 TAOK2 DHX15 ZPR1 PLCB3 TGFB1 PCSK6 PCSK7 UBASH3B CDH1 RCN3 CDH17 MYBPC3 | 2.79e-03 | 848 | 207 | 14 | EFO_0004614 |
| Disease | response to antihypertensive drug | 2.98e-03 | 41 | 207 | 3 | EFO_0005405 | |
| Disease | hepatocellular carcinoma | 2.98e-03 | 41 | 207 | 3 | EFO_0000182 | |
| Disease | alcohol consumption measurement | SPI1 KDM4C ACTN1 TENM2 GFRA2 DHX15 PTPRK PLEKHM2 PLCB3 DPP6 SGIP1 CALU GLRA3 CLIC6 ABI2 ARHGAP27 EPHA4 MYBPC3 | 3.01e-03 | 1242 | 207 | 18 | EFO_0007878 |
| Disease | cortical surface area measurement | DCHS2 PCNX3 SRPK2 PLXNB2 TENM2 GLRA1 WNK2 FLNB ANO2 STRN3 COL11A1 ABI1 PSTPIP1 RASGEF1B ARHGAP27 FGD6 PRLR RHOT1 EPHA4 | 3.07e-03 | 1345 | 207 | 19 | EFO_0010736 |
| Disease | iron biomarker measurement, serum iron measurement | 3.09e-03 | 12 | 207 | 2 | EFO_0004461, EFO_0006332 | |
| Disease | serum iron measurement | 3.19e-03 | 86 | 207 | 4 | EFO_0006332 | |
| Disease | multiple sclerosis | HOXA1 GLB1 PTPRK IKZF3 SH3BP2 KCP RCBTB1 ARHGAP27 UBASH3B CDH3 MYBPC3 | 3.33e-03 | 594 | 207 | 11 | MONDO_0005301 |
| Disease | Proteinuria | 3.42e-03 | 43 | 207 | 3 | C0033687 | |
| Disease | carpal tunnel syndrome | 3.61e-03 | 89 | 207 | 4 | EFO_0004143 | |
| Disease | high grade glioma (implicated_via_orthology) | 3.65e-03 | 44 | 207 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.65e-03 | 145 | 207 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | DCHS2 RBM26 PLXNB2 F3 TAOK2 IQCJ-SCHIP1 ROBO3 WNK2 ANO2 STRN3 COL11A1 NXPH1 ARHGAP27 TMC5 FGD6 EPHA4 | 3.74e-03 | 1069 | 207 | 16 | EFO_0004346 |
| Disease | Malignant neoplasm of salivary gland | 3.89e-03 | 45 | 207 | 3 | C0220636 | |
| Disease | phosphatidylcholine measurement | 4.06e-03 | 284 | 207 | 7 | EFO_0010226 | |
| Disease | nicotine dependence symptom count | 4.14e-03 | 285 | 207 | 7 | EFO_0009262 | |
| Disease | iron biomarker measurement, transferrin saturation measurement | 4.22e-03 | 14 | 207 | 2 | EFO_0004461, EFO_0006333 | |
| Disease | wet macular degeneration | 4.22e-03 | 14 | 207 | 2 | EFO_0004683 | |
| Disease | sickle cell anemia (is_marker_for) | 4.22e-03 | 14 | 207 | 2 | DOID:10923 (is_marker_for) | |
| Disease | asthma exacerbation measurement | 4.22e-03 | 93 | 207 | 4 | EFO_0007614 | |
| Disease | Salivary Gland Neoplasms | 4.40e-03 | 47 | 207 | 3 | C0036095 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.73e-03 | 96 | 207 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | phosphoenolpyruvic acid measurement | 4.84e-03 | 15 | 207 | 2 | EFO_0010522 | |
| Disease | interleukin 18 receptor 1 measurement | 4.84e-03 | 15 | 207 | 2 | EFO_0008178 | |
| Disease | prostate cancer (is_marker_for) | 4.97e-03 | 156 | 207 | 5 | DOID:10283 (is_marker_for) | |
| Disease | cardiovascular disease | 5.19e-03 | 457 | 207 | 9 | EFO_0000319 | |
| Disease | Adenoid Cystic Carcinoma | 5.46e-03 | 100 | 207 | 4 | C0010606 | |
| Disease | hypertension (biomarker_via_orthology) | 5.48e-03 | 227 | 207 | 6 | DOID:10763 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NESIYYEPLEFIDPS | 641 | Q76B58 | |
| PEPYILVYANDAAIS | 236 | P12645 | |
| YPPLDIDISYNAFEI | 96 | Q9P2K9 | |
| YPSEYAEIDKAPDES | 371 | Q7Z7A1 | |
| AIAQELNELDYYDSP | 456 | P12814 | |
| EYDNEPQIPGYIVDD | 86 | P15514 | |
| DYSFYLADEPAAIVP | 96 | A8MYA2 | |
| YPLALSPIYEDDSSQ | 2081 | Q68DQ2 | |
| DLPSYLFPEDPSYDA | 271 | P54646 | |
| QPQEVLVDYYIDPAD | 466 | A8K2U0 | |
| LVDYYIDPADASPDQ | 471 | A8K2U0 | |
| DISLSPYPTDNEDYE | 161 | P78314 | |
| AEEPEYAYHIPSSLD | 431 | Q86SQ6 | |
| SEPLAAADIPAYYIS | 286 | A6NHX0 | |
| EYYLEEEQGPADHPS | 311 | Q9BYV8 | |
| FALEPQLSPGEDYYE | 291 | A0A1B0GVH6 | |
| AAVVQYNDPYADGDP | 426 | Q8IZP0 | |
| YEFYEPDDSLENSPP | 506 | Q5JTC6 | |
| NATYGYVLDDPDPDD | 131 | O43852 | |
| AAYPLHDGEYDSPED | 311 | Q9NQ90 | |
| IFYTPEPERDYLEAA | 321 | O43143 | |
| YLNSPLPDEIDAYST | 606 | Q96NY7 | |
| FYDAPPDQAADLAYQ | 256 | Q9H7Y0 | |
| IPEDLRDPFYVDQYE | 56 | Q5T5Y3 | |
| SRDHYPLVEEDYPDS | 481 | O00305 | |
| PLVEEDYPDSYQDTY | 486 | O00305 | |
| AAVVEYSDPYAEEDP | 431 | Q9NYB9 | |
| YPQEDYESFSLPESV | 216 | Q7Z401 | |
| NDFYDGSYDDPSVPL | 276 | Q8NFF2 | |
| PEYECYAPDTEELEA | 311 | Q8N0V3 | |
| QEPRSDYYNHEVPDI | 621 | Q7Z5L2 | |
| QVEEYIADLYSAEPG | 221 | Q96D15 | |
| QYLYTDTVDLPPEDA | 426 | Q8NDN9 | |
| DTYDTDGYNPEAPSI | 426 | Q5T8P6 | |
| PREDASPEELNRYYA | 36 | P10082 | |
| LESLQDGAAESPYAY | 31 | Q96S21 | |
| SSPDDPNYSLVDDYS | 316 | Q9H939 | |
| FEAPSPLGAVDLYEY | 551 | Q9Y5P8 | |
| LAYSEYPDDSLDLDP | 106 | O75311 | |
| DFSYLEALAPYQPLA | 426 | Q9NV88 | |
| SPDVVYGPEAIEAQY | 11 | Q9NPH2 | |
| TDIDPDVAYSSVPYE | 371 | P09960 | |
| LDINDNPPVFEYREY | 3221 | Q14517 | |
| PNYEVIDEQTPLYSA | 4401 | Q14517 | |
| LQQPDDYESYLEGAV | 186 | O94952 | |
| PEDTYQDPRGIYDQV | 1206 | O60500 | |
| ALYDYTAQNPDELDL | 366 | O43586 | |
| SYLPQPYAELEEVSS | 86 | P59103 | |
| GSESYEEDPYLVVNP | 801 | Q14566 | |
| DTTAVPYVFQDDPYL | 81 | Q96EY7 | |
| GDYVYVEPAEANLQP | 961 | Q86U86 | |
| YAESILNPDAFIAYP | 286 | Q17RR3 | |
| YSYNPDLDSDPFGED | 166 | Q9H063 | |
| SDYVFDGTNPPYREE | 136 | Q9NZL9 | |
| DPQSVTLYSGEDYPD | 796 | O00533 | |
| ECSPYAAHLYDAEDP | 86 | Q96JK4 | |
| DTEIPNELPYNDYFE | 321 | Q13547 | |
| SQPALPEDLYAFSYN | 101 | Q96EF0 | |
| PYQDGPDISYLEVED | 941 | Q9P2D0 | |
| SPYESAIGEEYEEAP | 421 | Q9UQF2 | |
| ELYSVPPDRVDEEYQ | 371 | P46020 | |
| ELEYQLTEAYGVPDA | 356 | Q92485 | |
| QPYSYDFPEDVAPAL | 206 | P06681 | |
| EEELPYYVELPDRTA | 1086 | Q9Y3R5 | |
| PQEYQYFDELSGIPA | 451 | Q96KR4 | |
| YYVSLAVSEEPPEDG | 306 | Q8TDN1 | |
| ENIPDLPYDYSSSLE | 126 | P50747 | |
| AQPTSYDYDAPLSEA | 326 | P16278 | |
| YDYDAPLSEAGDLTE | 331 | P16278 | |
| YVDPFTYEDPNQAVR | 596 | P54764 | |
| EDVLELSSSPEPAYY | 5686 | Q5CZC0 | |
| PQIDEYAPEDIIEYD | 256 | P12107 | |
| VNPEYFSAADVYVPD | 976 | P08069 | |
| SPPAEFIYYCVDEDE | 311 | Q9UIS9 | |
| ENLYASEEPAVYEPS | 31 | P41279 | |
| YIDPFTYEDPNEAVR | 596 | P29323 | |
| EYIPFAPGDYDVNIT | 1386 | O75369 | |
| FTSPDEYDDPTVLYE | 1866 | Q96RV3 | |
| QFTCPDEYEDPAVLY | 1701 | A6NKB5 | |
| DEYEDPAVLYEAIQS | 1706 | A6NKB5 | |
| SPDEYEEPAALYDAI | 1656 | Q9H6A9 | |
| DVNGNDYDPSPRYDA | 226 | P29122 | |
| DYDPSPRYDASNENK | 231 | P29122 | |
| DIAPNYSPEGSYDLN | 196 | Q16549 | |
| YSPEGSYDLNSNDPD | 201 | Q16549 | |
| YYDEIINALEEDPAA | 1801 | O15031 | |
| PYQLPSDVGLENYDS | 321 | Q1X8D7 | |
| YDDDLDLTPEYLFPL | 276 | Q8IXI2 | |
| YAVPYVLPEDEDTEE | 471 | Q14999 | |
| FIYSEENIEYSPPNA | 691 | Q9H3R0 | |
| EANYEAVPVEAYGLA | 156 | Q92917 | |
| APYSPYALNQEADVS | 106 | P49639 | |
| VDYYESLLDDSIDPA | 346 | Q8IVL5 | |
| SYDVYIEENNLPGAP | 461 | Q9UN70 | |
| ELPYTFAAPESYEEL | 421 | P78316 | |
| DALYLASYESEGPEN | 441 | Q0VAM2 | |
| PADELYAALEDYHPA | 51 | Q7Z6J2 | |
| EENYSRPEAPNEFYD | 401 | O15379 | |
| SVASESDYAIPPDAY | 661 | Q8IVE3 | |
| SDYAIPPDAYSTDTE | 666 | Q8IVE3 | |
| YTFLVYEDVPEDSPI | 881 | Q6V1P9 | |
| EYANYTVPEDATPDA | 301 | P38405 | |
| REPYEAQQSEPIAYF | 281 | Q8NA29 | |
| DDAYPLYSDFQPPAL | 371 | P06401 | |
| PALLIYTEASDYIPD | 836 | Q01970 | |
| DPSRYISPDQLADLY | 266 | P06733 | |
| ISESLPEYFAPYQAE | 76 | O60308 | |
| EGAYDPADYEHLPVS | 61 | Q9NQC8 | |
| ELQDYVEDTSEYLAP | 711 | Q659A1 | |
| LDELYEFPEYSRDPT | 291 | Q8NB78 | |
| SYSNPVRQPLYEFED | 391 | O95352 | |
| SVVDTYLYPDPEDVF | 111 | Q92874 | |
| PPGDHDYIYNLDESE | 386 | Q16254 | |
| LTEGEEFYEASPYEP | 116 | O00451 | |
| LGNYELDVSPYEDTV | 126 | O60609 | |
| AEDLDALQAAEYFYP | 111 | A8K830 | |
| YAEYLQPSAKRPDAD | 16 | Q9Y5T4 | |
| YDLYTIPKDADSQNP | 391 | P53621 | |
| SFPAPLYSDDYLSLE | 21 | A6NCJ1 | |
| PPPQDYESDDDSYEV | 6 | Q8IVP5 | |
| SESYQEDIYPPTAGA | 361 | Q92828 | |
| RTNEIYYLDPDAPLS | 851 | A2RUB6 | |
| HAYEPTPDDVAISYL | 291 | Q9ULC5 | |
| DPEDESAYAVQYRPE | 111 | Q02410 | |
| YGPASVPEYEARTED | 281 | Q9Y6X4 | |
| NPFEETADGDVYYPE | 531 | Q99698 | |
| DRRYDEVPSDLPYQD | 11 | Q8N4S9 | |
| YAGSLAEPYEELEAE | 1521 | Q8N2S1 | |
| DPFNSEPETLEYYTE | 746 | Q16760 | |
| TEDADPYVQPEDENY | 696 | Q9Y4J8 | |
| RDDPLVLYVYAAPQD | 571 | Q7Z6J4 | |
| SFEIENPYSPYIQDL | 206 | A4D0S4 | |
| FYEPDAYDDLDQEDP | 296 | Q8TE02 | |
| YPPEVAEFVYITDDT | 271 | P20248 | |
| PDREYALFSYNVEPI | 196 | P42658 | |
| EPEADQDGYYQTTLP | 411 | O60645 | |
| LDCEIPNELPYNDYF | 321 | Q92769 | |
| LAAYPAETPTAGEEY | 106 | Q92826 | |
| EEPEIPYSYSREYNE | 81 | Q9UKT9 | |
| TDLDDPATPNGQLYY | 151 | Q12864 | |
| AVDEVEPLPEDYYTR | 221 | Q9UJW0 | |
| YDVSPIAYEDYSPDD | 711 | Q8NFT8 | |
| DPVLGEDYYSVENPA | 271 | P14778 | |
| APPYDTLLVFDYEGS | 771 | P22223 | |
| LLPPEDDTRDNVYYY | 741 | P12830 | |
| AEELDVPVYLYGEAA | 116 | O95954 | |
| PVEDDPSSDYINANY | 931 | Q15262 | |
| PEVYVPTVFENYIAD | 31 | P08134 | |
| NEYPDLEEERATYPQ | 161 | Q0VD86 | |
| DYVDSIDVPDSYNGP | 96 | O14829 | |
| FELDLDAPYLDLAPY | 151 | Q8IWE5 | |
| YIDPDTYEDPSLAVH | 606 | Q9UF33 | |
| NDLQDDSLYLPPCYD | 191 | Q9GZS1 | |
| DPGDESTVYIPEAEY | 1881 | P0C091 | |
| PPDSEAYYGETDSDA | 131 | Q9H987 | |
| YVVDNSRPPTDLEYD | 221 | Q8N1G1 | |
| YDYDPRESSPNVDVE | 961 | O15034 | |
| PEVYVPTVFENYVAD | 31 | P61586 | |
| PEVYVPTVFENYVAD | 31 | P62745 | |
| SVDPYDTYEPNVLAG | 566 | Q13033 | |
| DYYIAQGLSEDQLAP | 56 | Q9H1X1 | |
| VQLYDTPYEEQDPET | 141 | Q96IW2 | |
| LYDTPYEPEGQSVDS | 296 | Q15464 | |
| EQLAYGFTELPDAPY | 366 | Q1RMZ1 | |
| DLDLRYDTPEPYSEQ | 71 | P58417 | |
| VSALEDYEEPFPVYQ | 71 | P0DPB3 | |
| YLGESYLSNQEFPDP | 786 | Q6ZWJ8 | |
| LAYNEYPDDSLDLDP | 101 | P23415 | |
| YYRQAEEPDSPDSVS | 131 | O15197 | |
| YELYDDVEPRDDSSP | 506 | Q96QH2 | |
| AAPEPLAYDYRFVSA | 86 | Q6ZUM4 | |
| EIGYEDPINPTYEAT | 456 | O43272 | |
| VSEPLEDLDPYYADK | 71 | Q15858 | |
| PEYYEAFNRLLEDPV | 106 | P0DUX0 | |
| PEYYEAFNRLLEDPV | 106 | P0DTA3 | |
| PEYYEAFNRLLEDPV | 106 | P0DUD1 | |
| ENDPAYILNDLYISD | 371 | Q6PI26 | |
| EGAPLSDLEYYSNDL | 246 | Q9UNP4 | |
| GSDNLYDDPYQPEIT | 421 | Q9UL54 | |
| YVLPVEQYPELADSS | 2746 | Q9NT68 | |
| YLAEDPEPQEAAYLI | 101 | Q6NVH7 | |
| PNTPSRAEEEYEYAF | 826 | O00267 | |
| YEYAFDDEPTPSPQA | 836 | O00267 | |
| PSEDLVPYDTDLYQR | 16 | P17947 | |
| LVSALEDYEEPFPVY | 146 | B3KU38 | |
| SYPSAINEEESYPDG | 536 | Q8TEV9 | |
| NLAPSQLEYYASSPD | 516 | Q9Y2G3 | |
| ELYPAPRESYDADGT | 411 | Q5VXH4 | |
| SPSRQPVYYDELDAA | 426 | Q9Y2H5 | |
| NSYLQNVYAPEDDPE | 411 | O75312 | |
| APLDELVGAYPNYNE | 31 | Q9H1C4 | |
| SDDIYNQVSAYPLPE | 231 | Q12768 | |
| NFNRDSLYPYLEDIP | 86 | O95497 | |
| PADYAEPANTDDNYG | 201 | Q14157 | |
| DHLSYETPYETPQDE | 906 | Q8NB66 | |
| NYAAPSPYVESEDAP | 331 | P04198 | |
| SYNEVYAEEVPQAPA | 36 | O60687 | |
| YAEEVPQAPALDYRV | 41 | O60687 | |
| LVDEEYELYQDPSPS | 871 | Q8NI35 | |
| DPAESVLNYFEPYLG | 4016 | Q15413 | |
| YNSPELDEEGYSIRP | 76 | Q9BQI5 | |
| YPGQDPVDLDIYQSS | 6 | Q96LM6 | |
| PEYYEAFNRLLEDPV | 106 | P0DUX1 | |
| PEYYEAFNRLLEDPV | 106 | A0A494C0Z2 | |
| PEYYEAFNRLLEDPV | 106 | P0DUD3 | |
| PEYYEAFNRLLEDPV | 106 | P0DUD4 | |
| PEYYEAFNRLLEDPV | 106 | P0DUD2 | |
| NPDPDDRYYNEAGIS | 986 | Q96MS0 | |
| ESAEPEPEPEADYYA | 91 | P01137 | |
| NYFYVPDLGQVPEID | 231 | Q6VEQ5 | |
| DYEYEEIPDDNFSIP | 56 | Q8N0X2 | |
| PEEYNLDEPNAESDY | 411 | P78362 | |
| EYYTEPEVAESDAAP | 146 | Q96J42 | |
| ADANVYEVEEPYEAP | 786 | Q6ZV73 | |
| YEVEEPYEAPDGQLQ | 791 | Q6ZV73 | |
| ELYPAPRESYDADGT | 411 | Q5TYX0 | |
| QSDPYSVPARDYLID | 96 | P18206 | |
| FPPTSDYEDLLVEYL | 301 | P16471 | |
| LAEPAYEADVAQLEY | 736 | O43847 | |
| CLELYPAPQESYGAD | 411 | O60813 | |
| GDNVEAPPVYDSYEV | 476 | Q53EL9 | |
| YENSPEFTPYLETNL | 126 | P13726 | |
| PDYLPYAEDESVDDL | 311 | O43290 | |
| YSEPVDQEYLPEELR | 641 | Q96S55 | |
| PTERDLVYYEASPNF | 266 | P56704 | |
| TVGADVPPASDYYDA | 171 | P0C7W0 | |
| PEYYEAFNRLLEDPV | 106 | A0A494C191 | |
| EQPRTDVAFYPNYED | 126 | Q96Q05 | |
| EEDPDYPDYSGSQNR | 11 | Q6UXY8 | |
| VIYPYTPQNDDELEL | 261 | Q8TF42 | |
| SLRYSAPPDVYLDEA | 1801 | Q9Y3S1 | |
| TLYPYLREEDLDDSP | 531 | Q6ZSZ6 | |
| DPEDGVQFPLDYNYS | 216 | Q8TD43 | |
| SAAVPYRAEYEVDPE | 186 | Q8IU80 | |
| YDDIAYSEDNPTPGI | 71 | Q99538 | |
| ILYSDPADYFAPEVQ | 216 | Q9Y3Q0 | |
| REYTGFPDPYDELNT | 511 | Q9NZM1 | |
| TYEPPNYKALDFSEA | 1166 | Q14896 |